Abstract
A sheep was immunized with a synthetic peptide corresponding to amino acid residues 586–606 of the precursor envelope protein GP-160 of the HIV-1 including a conserved epitope region of the GP-41 transmembrane protein in the mature viral particles, referred to as SM 284 HIV-1 [1]. It is demonstrated that immune RNA extracted from the lymphoid organs of the immunized animal (SM 284 HIV-1 I-RNA) was able to transfer immune cellular reactivity to SM 284 HIV-1 in vitro to human and rabbit lymphocytes and in vivo to Cebus apella monkeys. The transfer was detected by the leukocyte adherence inhibition test (LAI) as an indicator of cellular reactivity. One of the most relevant results was the demonstration that SM 284 HIV-1 I-RNA was able to induce cellular immunological memory in vivo in monkeys. These results may be relevant to delineate a new alternative for immunomodulation against HIV infection.
Similar content being viewed by others
Abbreviations
- A:
-
Absorbance
- ATA:
-
Aurintricarboxylic acid
- cDNA:
-
Complementary DNA
- DNase:
-
Deoxyribonuclease
- env:
-
Envelope
- ELISA:
-
Enzyme Linked Immunosorbent Assay
- MEM:
-
Minimum Essential Medium
- gp:
-
Glycoprotein
- HBV:
-
Hepatitis B Virus
- HIV:
-
Human Immunodeficiency Virus
- LAI:
-
Leukocyte Adherence Inhibition
- RNase:
-
Ribonuclease
- PK:
-
Proteinase K
- SDS:
-
Sodium Dodecyl Sulfate
References
Wang JJG, Steel S, Wisniewolski R, Wang CY: Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp 41 envelope protein. Proc Natl Acad Sci USA 83: 6159–6183, 1986
Dalgleish AG, Beverley PCL, Clapham PR, Crawfor DH, Greaves MF, Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763–767, 1984
Klatzman D, Champagne E, Chamaret S, Gruest J, Guetard, Hercent T, Gluckman JC, Montagnier L: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312: 767–768, 1984
Wahren B, Morfeldt-Mansson L, Biberfeld G, Morberg L, Ljungman P, Nordlund S, Bredeberg-Radén U, Werner A, Lower J, Kurt R: Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection. New Engl J Med 315: 393–394, 1986
Weiss RA, Claphan PR, Ceingsong-Popov R: Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature 316: 69–72, 1985
Popovic M, Sarngadharan MG, Read E, Gallo R: Detection, isolation and continuous production of cytopathic retro-virus (HTLV-III) from patients with AIDS and pre-AIDS. Science 224: 497–500, 1984
Plata F, Autran B, Martins LP, Wain-Hobson S, Raphael M, Mayaud C, Denis M, Guillon JM, Debré P: AIDS - virus specific cytotoxic T lymphocytes in lung disorders. Nature 328: 348–351, 1987
Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blunberg RS, Kaplan J, Hirsch MS, Schooleys RT: HIV-specific cytotoxic T lymphocytes in seropositive individuals: Nature 328: 345–347, 1987
Walker BD, Flexner C, Paradis TJ, Fuller TC, Hirsch MS, Schooley R, Moss B: HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals: Science 240:64–66, 1988
Walker CM, Moody DJ, Stiles DP, Levy JA: CD8+ lymphocytes can control HIV infection in vitro by suppression virus replication. Science 234: 1563–1566, 1986
Alter HJ, Eichberg JW, Masur H, Saxinger W, Macher AM, Lane HC, Fauci AS: Transmission of HTLV-III infection from human plasma to chimpanzees. An animal model for AIDS. Science 226: 549–552, 1984
Francis DP, Feorino PM, Braderson JR, McClure HM, Getchel JP, McGrath CR, Swenson B, McDougal JS, Palmer EL, Harrison AK, Barré-Sinoussi F, Chermam JC, Montagnier L, Curran JW, Cabradilla CD, Kalyanamaran VS: Infection of chimpanzees with lymphadenopathy associated virus. Lancet 2: 1276–1277, 1984
Gajdusek C, Gibbs Jr CJ, Roberts-Johnson P, Amyx HL, Asher DM, Epstein LG, Sarin PS, Malvish A, Gallo RC, Arthur L, Montagnier L, Mildvan D: Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients. Lancet 1: 55–56, 1985
Claverie JM, Kourilsky P, Langlade-Demoyen P, Chalufour-Prochnicka A, Dadaglio G, Tekaia F, Plata F, Bougueleret L: T-immunogenic peptides are constituted of rare sequence patterns. Use in the identification of T epitopes in the human immunodeficiency virus gag protein Eur J Immunol 18: 1547–1553, 1988
Michel F, Hoffenbach A, Langlade-Demoyen P, Guy B, Girard M, Lecocq JP, Wain-Hobson S, Kieny MP, Plata F: HIV-specific T lymphocytes immunity in mice immunized with a recombinant vaccinia virus. Eur J Immunol 18: 1917–1924, 1988
Mendes NF, Peixinho ZF, Longo IM, Moura NC, Beck C, Passos Jr GAS, De Lucca FL: Transfer of cell-mediated immunity to HIV antigens in vivo to a Cebus monkey and in vitro to human lymphocytes with xenogeneic immune RNA. Braz J Med Biol Res 20: 747–751, 1986
Passos Jr GAS: Transferência in vitro e in vivo de imunidade celular a um peptídeo sintético contendo um dos epítopos da glicoproteína 41 do vírus da imunodeficiência humana — 1 (HIV-1) com RNA imune. Doctoral Thesis, School of Medicine of Ribeirão Preto, University of São Paulo pp. 1–156, 1988
De Lucca FL, Bertolini MC, Zini MN: In vitro transfer of reactivity to Trypanosoma cruzi antigens from rat cells to human cells with immune RNA. J Infect Dis 145: 148–151, 1982
Passos Jr GAS, De Lucca FL: In vivo induction of immunological memory to human tumor extract with poly (A) containing immune RNA. Cell Mol Biol 34: 157–164, 1988
Steele Jr G, Wang BS, Mannick JA: Immune RNA and transfer factor. In: Mihich E, (editor). Imunological approaches to cancer therapeutics. New York, USA: John Wiley and Sons, Inc., 1982, 257–275
Artigas C, Thomson DMP, Durno M, Sutherland M, Scanzano R, Shenouda G, Dubois AEJ: Identification of Mr 40,000 polypeptide from colorectal cancer with expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition. Cancer Res 46: 1874–1881, 1986
Grossner N, Thomson DMP: Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes. Cancer Res 35: 2571–2579, 1975
Merrifield RB: Solid phase peptide synthesis I. The synthesis of a tetrapeptide. J Am Chem Soc 85: 2149–2154, 1963
White BN, De Lucca FL: Preparation and analysis of RNA. In: Turner RB, (editor). Analytical Biochemistry of Insects. Amsterdam, Holand: Elsevier-Scientific, 1977, 85–130
Matews MB: Mammalian chain initiation: the effect of aurin tricarboxylic acid. FEBS Letters 15: 201–204, 1971
Mackie CM, Buxton DB, Mowbray J: Aurin tricarboxylic acid as both a stimulator and an inhibitor of cell-free protein synthesis by heart polyribosomes. Biochem Biophys Res Comm 144: 750–757, 1982
Kuwano H, Scott M, Young JF, Ennis FA: HA2 Subunit of influenza H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T-lymphocyte response. J Immunol 140:1264–1268, 1988
Taylor PM, Asconas BA: Influenza nucleoprotein specific T-cell clones are protective in vivo. Immunol 58: 417–420, 1986
Shi-Shan L, Chang Fu L, Fu-Ying H, Chang-Xue Z: Preparation and clinical use of HBsAG immune RNA. Lancet 1: 197–198
Viza D, Boucheix C, Kern DH, Pilch Y: Human lymphoblastoid cells in culture replicate immune information carried by xenogeneic RNA. Differentiation 11: 181–184, 1978
Zucchi TMAD, Passos Jr GAS, De Lucca FL: RNA-mediated genetic transformation in Aspergillus nidulans. Cell Mol Biol 35: 573–580, 1989
Niu MC, Xue GX, Niu LC, Huang HZ: Transfer of information from mRNA to chromosomes by reverse transcription in early development of goldfish eggs. Cell Mol Biol 35: 333–345.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Passos, G.A.S., de Lucca, F.L. RNA-mediated transfer of cellular immunity to a synthetic env antigen of the human immunodeficiency virus (HIV-1). Mol Cell Biochem 108, 1–8 (1991). https://doi.org/10.1007/BF00239536
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00239536